Itaconix PLC (GB:ITX)
LSE:ITX
Top Page
Itaconix
(LSE:ITX)
Select Model
Select Model
Rating:49Neutral
Price Target:
114.00 p
▲(6.05% Upside)
Action:ReiteratedDate:03/26/26
The score is held back primarily by weak financial performance, especially persistent negative operating/free cash flow and continued losses despite revenue scaling. Technical indicators are mixed with only moderate momentum, and valuation lacks support due to negative earnings. The earnings call adds some offset from strong growth and improving EBITDA trajectory, but margin and customer concentration risks remain.
Positive Factors
Revenue Growth / Scale
Sustained revenue expansion over multiple years demonstrates improving commercial traction and broader adoption of its bio-based ingredients. Growing scale helps dilute fixed costs, strengthens negotiating leverage with customers and suppliers, and raises the probability of reaching sustainable profitability as volumes increase.
Negative Factors
Persistent Cash Burn
Consistent negative operating and free cash flow show the business is not self-funding and relies on external capital. Persistent cash burn constrains strategic options, increases risk of dilution or costly financing, and can slow customer conversion and scale initiatives if additional funding is delayed or unavailable.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth / Scale
Sustained revenue expansion over multiple years demonstrates improving commercial traction and broader adoption of its bio-based ingredients. Growing scale helps dilute fixed costs, strengthens negotiating leverage with customers and suppliers, and raises the probability of reaching sustainable profitability as volumes increase.
Read all positive factors
Itaconix (ITX) vs. iShares MSCI United Kingdom ETF (EWC)
Market Cap
£14.16M
Dividend YieldN/A
Average Volume (3M)8.23K
Price to Earnings (P/E)―
Beta (1Y)0.02
Revenue Growth25.56%
EPS Growth35.12%
CountryUK
Employees22
SectorBasic Materials
Sector Strength58
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)N/A
Shares Outstanding13,486,122
10 Day Avg. Volume5,692
30 Day Avg. Volume8,228
Financial Highlights & Ratios
PEG Ratio0.36
Price to Book (P/B)1.76
Price to Sales (P/S)1.35
P/FCF Ratio-7.78
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Itaconix Business Overview & Revenue Model
Company Description
Itaconix (ITX) is a sustainable materials company that specializes in the development and production of innovative biopolymers derived from renewable resources. Operating primarily in the specialty chemicals sector, Itaconix focuses on delivering ...
How the Company Makes Money
Itaconix makes money primarily by selling proprietary, bio-based specialty chemical ingredients to formulators and manufacturers that incorporate these ingredients into finished products (e.g., detergents, cleaners, and other formulated goods). Re...
Itaconix Financial Statement Overview
Summary
Income Statement
28
Negative
Balance Sheet
55
Neutral
Cash Flow
22
Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 10.72M | 6.50M | 6.17M | 4.57M | 2.60M |
| Gross Profit | 3.72M | 2.26M | 1.93M | 1.49M | 518.89K |
| EBITDA | -1.06M | -1.52M | -1.06M | -1.78M | -58.17K |
| Net Income | -1.41M | -1.86M | -1.54M | -2.01M | -330.83K |
Balance Sheet | |||||
| Total Assets | 12.96M | 13.18M | 11.98M | 2.06M | 2.43M |
| Cash, Cash Equivalents and Short-Term Investments | 4.39M | 6.73M | 6.86M | 493.85K | 506.29K |
| Total Debt | 2.02M | 1.97M | 2.45M | 428.08K | 366.19K |
| Total Liabilities | 4.72M | 3.85M | 3.10M | 2.69M | 1.95M |
| Stockholders Equity | 8.24M | 9.33M | 8.88M | -631.78K | 481.09K |
Cash Flow | |||||
| Free Cash Flow | -1.86M | -3.34M | -2.18M | -226.62K | -1.55M |
| Operating Cash Flow | -1.22M | -2.75M | -1.38M | -178.53K | -1.50M |
| Investing Cash Flow | -1.64M | 5.95M | -6.20M | -48.10K | -34.90K |
| Financing Cash Flow | -316.50K | -279.00K | 9.16M | 156.52K | 968.11K |
Itaconix Technical Analysis
Negative
107.50
Price Trends
113.01
Negative
114.07
Negative
117.11
Negative
Market Momentum
-2.25
Positive
39.80
Neutral
39.89
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:ITX, the sentiment is Negative. The current price of 107.5 is below the 20-day moving average (MA) of 107.75, below the 50-day MA of 113.01, and below the 200-day MA of 117.11, indicating a bearish trend. The MACD of -2.25 indicates Positive momentum. The RSI at 39.80 is Neutral, neither overbought nor oversold. The STOCH value of 39.89 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:ITX.
Itaconix Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | £4.14B | 60.70 | 6.17% | 3.45% | 2.36% | -13.99% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
58 Neutral | £917.76M | -28.06 | -6.85% | 1.34% | -11.78% | -92.61% | |
53 Neutral | £7.05M | -2.27 | -69.24% | ― | -24.85% | 40.28% | |
51 Neutral | £76.63M | -1.25 | -8.05% | ― | -4.41% | 2.29% | |
49 Neutral | £14.16M | -3.72 | -19.63% | ― | 25.56% | 35.12% | |
41 Neutral | £25.27M | -2.65 | ― | ― | -27.64% | 35.09% |
* Basic Materials Sector Average
GB:ITX
Itaconix
107.50
-2.00
-1.83%
GB:CRDA
Croda International
2,934.00
370.45
14.45%
GB:DCTA
Directa Plus
6.75
-0.50
-6.90%
GB:ELM
Elementis
156.20
35.94
29.89%
GB:HAYD
Haydale Graphene
0.32
0.19
137.04%
GB:SYNT
Synthomer
48.10
-36.50
-43.14%
Itaconix Corporate Events
Business Operations and StrategyFinancial Disclosures
Itaconix Hits Record Sales and Narrows Losses as Specialty Polymers Gain Traction
Positive
Mar 24, 2026
Itaconix reported record 2025 revenues of $10.5m, up 61% year on year, with gross profit exceeding $3m and margins holding at 35% as its core performance ingredients unit achieved a 41% margin. The company narrowed adjusted EBITDA losses to $0.6m,...
Business Operations and StrategyFinancial Disclosures
Itaconix Sets Date for 2025 Results and Investor Presentation
Positive
Mar 11, 2026
Itaconix plc, a developer of high-performance plant-based specialty polymers, plans to publish its preliminary financial results for the year ended 31 December 2025 on 24 March 2026, signaling an upcoming update on its trading performance and stra...
Regulatory Filings and Compliance
Itaconix Chair Increases Stake with Purchase of Additional Shares
Positive
Jan 16, 2026
Itaconix plc announced that its Non-Executive Chair, Peter Nieuwenhuizen, has purchased 8,000 ordinary shares in the company at 110.25 pence per share, increasing his holding to 33,457 shares, or approximately 0.2% of the company’s issued sh...
Business Operations and StrategyFinancial Disclosures
Itaconix Breaks $10m Revenue Barrier on Surging Demand for Plant-Based Polymers
Positive
Jan 13, 2026
Itaconix reported unaudited full-year 2025 revenues of $10.3 million, up 59% from 2024 and surpassing the $10 million mark for the first time, driven by a third consecutive record half-year with $5.5 million in second-half sales. Growth was broad-...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.